Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era

American Heart Journal

Volumn 150, Issue 5, 2005, Pages 887-892

  Jacob, Sonia ^a   Cohen, David J ^b   Massaro, Joseph ^b   Niemyski, Paulette ^b   Maresh, Kelly ^a   Kleiman, Neal ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c MS F 1090 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; DRUG ELUTING STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; STENT; TREATMENT OUTCOME; UNITED STATES;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DRUG DELIVERY SYSTEMS; HUMANS; REGISTRIES; STENTS;

EID: 27744522687     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.030     Document Type: Article

References (32)

1. D.L. Fischman, M.B. Leon, and D.S. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators N Engl J Med 331 1994 496 501
2. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Engl J Med 331 1994 489 495
3. P.W. Serruys, H.B. van, and H. Bonnier Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet 352 1998 673 681
4. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
5. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
6. D.R. Holmes Jr., M.B. Leon, and J.W. Moses Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640
7. D.G. Katritsis, E. Karvouni, and J.P.A. Ioannidis Meta-analysis comparing drug-eluting stents with bare metal stents Am J Cardiol 95 2005 640 643
8. G. Guagliumi, R. Virmani, and G. Musumeci Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patient Ital Heart J 4 2003 713 720
9. R. Virmani, A. Farb, and G. Guagliumi Drug-eluting stents: caution and concerns for long-term outcome Coron Artery Dis 15 2004 313 318
10. http://www.fda.gov/cdrh/safety/cypher.html
11. http://www.fda.gov/cdrh/safety/cypher3.html
12. REALITY Trial Presented by Dr MC Morice at the American College of Cardiology Annual Scientific Sessions 2005
13. E.P. McFadden, E. Stabile, and E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
14. E. Ferrari, M. Benhamou, and P. Cerboni Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis J Am Coll Cardiol 45 2005 456 459
15. M.J. Quinn, H.D. Aronow, and R.M. Califf Aspirin dose and six-month outcome after an acute coronary syndrome J Am Coll Cardiol 43 2004 972 978
16. S.J. Denardo, K.E. Davis, and P.R. Reid Efficacy and safety of minimal dose (< or = 1000 units) unfractionated heparin with abciximab in percutaneous coronary intervention Am J Cardiol 91 2003 1 5
17. R.R. Choussat, G. Montalescot, and J.P. Collet A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention J Am Coll Cardiol 40 2002 1943 1950
18. I. Muller, M. Seyfarth, and S. Rudiger Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement Heart 85 2001 92 93
19. A. Kastrati, J. Mehilli, and H. Schuhlen A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel N Engl J Med 350 2004 232 238
20. A.M. Lincoff, J.A. Bittl, and R.A. Harrington Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
21. M.N. Babapulle, L. Joseph, and P. Belisle A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591
22. R.L. Wilensky, F. Selzer, and J. Johnston Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI dynamic registry) Am J Cardiol 90 2002 216 221
23. A.D. Kugelmass, D.J. Cohen, and F. Houser The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database J Invasive Cardiol 15 2003 568 574
24. M.J. Mack, P.P. Brown, and A.D. Kugelmass Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures Ann Thorac Surg 77 2004 761 766
25. B.D. Powell, C.S. Rihal, and M.R. Bell Anticipated impact of drug-eluting stents on referral patterns for coronary artery bypass graft surgery: a population-based angiographic analysis Mayo Clin Proc 79 2004 769 772
26. A.E. Abdelmeguid, P.L. Whitlow, and S.K. Sapp Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure Circulation 91 1995 2733 2741
27. R.M. Califf, A.E. Abdelmeguid, and R.E. Kuntz Myonecrosis after revascularization procedures J Am Coll Cardiol 31 1998 241 251
28. S.J. Brener, B.W. Lytle, and J.P. Schneider Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality J Am Coll Cardiol 40 2002 1961 1967
29. D.F. Kong, V. Hasselblad, and R.A. Harrington Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions Am J Cardiol 92 2003 651 655
30. A. Jeremias, D.S. Baim, and K.K.L. Ho Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J Am Coll Cardiol 44 2004 1210 1214
31. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
32. P.R. Rosenbaum, and D.B. Rubin Reducing bias in observational studies using subclassification in the propensity score J Acoust Soc Am 79 1984 516 524